ATE491720T1 - Impfstoff gegen pasteurella multocida - Google Patents

Impfstoff gegen pasteurella multocida

Info

Publication number
ATE491720T1
ATE491720T1 AT05857856T AT05857856T ATE491720T1 AT E491720 T1 ATE491720 T1 AT E491720T1 AT 05857856 T AT05857856 T AT 05857856T AT 05857856 T AT05857856 T AT 05857856T AT E491720 T1 ATE491720 T1 AT E491720T1
Authority
AT
Austria
Prior art keywords
pasteurella multocida
vaccine against
bacteria
against pasteurella
vaccines
Prior art date
Application number
AT05857856T
Other languages
English (en)
Inventor
Yugang Luo
Paul Vermeij
Antonius Jacobs
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE491720T1 publication Critical patent/ATE491720T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT05857856T 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida ATE491720T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63944704P 2004-12-22 2004-12-22
PCT/EP2005/056995 WO2006122586A1 (en) 2004-12-22 2005-12-21 Pasteurella multocida vaccine

Publications (1)

Publication Number Publication Date
ATE491720T1 true ATE491720T1 (de) 2011-01-15

Family

ID=36677027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857856T ATE491720T1 (de) 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida

Country Status (14)

Country Link
US (1) US8309101B2 (de)
EP (1) EP1831248B1 (de)
JP (1) JP4981684B2 (de)
KR (1) KR20070092290A (de)
CN (1) CN101087803B (de)
AT (1) ATE491720T1 (de)
AU (1) AU2005331860B2 (de)
BR (1) BRPI0519381A2 (de)
CA (1) CA2591624A1 (de)
DE (1) DE602005025404D1 (de)
MX (1) MX2007007570A (de)
RU (1) RU2415926C2 (de)
WO (1) WO2006122586A1 (de)
ZA (1) ZA200705087B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
CN101948791A (zh) * 2010-09-21 2011-01-19 华东理工大学 一种溶藻弧菌野生毒株的无标记基因缺失减毒突变株、相关制剂及应用
RU2455024C1 (ru) * 2010-12-30 2012-07-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи Министерства здравоохранения и социального развития РФ" Аттенуированные бактерии bordetella pertussis, вакцина против возбудителя коклюша
RU2460791C1 (ru) * 2011-07-28 2012-09-10 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ аттенуации вакцинного туляремийного штамма
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9642905B2 (en) 2013-03-18 2017-05-09 Intervet Inc. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
CN104560854B (zh) * 2015-01-07 2018-03-02 四川农业大学 缺失phoP的禽多杀性巴氏杆菌减毒菌株及其构建方法和应用
CN106114241A (zh) * 2016-06-28 2016-11-16 无锡新大力电机有限公司 一种含有冷却水套的太阳能电动汽车
CN109847060A (zh) * 2019-04-19 2019-06-07 黑龙江八一农垦大学 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法
CN110205395A (zh) * 2019-06-17 2019-09-06 武汉科前生物股份有限公司 副猪嗜血杆菌的血清分型方法、引物组合以及pcr体系

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2148829A1 (en) * 1992-11-06 1994-05-26 Keum Hwa Choi Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
ATE420105T1 (de) * 2002-04-05 2009-01-15 Merial Sas Attenuirte gram-negative bakterien
JP2004242608A (ja) * 2003-02-17 2004-09-02 Nitsuseiken Kk 無毒変異型パスツレラ・ムルトシダ毒素とその遺伝子および製法
UA65107A (en) * 2003-05-30 2004-03-15 Vasyl Petrovych Ryzhenko Pasteurella multocida "z-40/155" strain for production of vaccine against pasteurellosis of livestock

Also Published As

Publication number Publication date
EP1831248A1 (de) 2007-09-12
MX2007007570A (es) 2007-07-24
KR20070092290A (ko) 2007-09-12
CA2591624A1 (en) 2006-11-23
US8309101B2 (en) 2012-11-13
JP2008523840A (ja) 2008-07-10
BRPI0519381A2 (pt) 2009-01-20
RU2007128047A (ru) 2009-01-27
US20100062017A1 (en) 2010-03-11
CN101087803A (zh) 2007-12-12
ZA200705087B (en) 2008-08-27
CN101087803B (zh) 2012-01-18
DE602005025404D1 (de) 2011-01-27
RU2415926C2 (ru) 2011-04-10
JP4981684B2 (ja) 2012-07-25
AU2005331860B2 (en) 2011-08-11
AU2005331860A1 (en) 2006-11-23
WO2006122586A1 (en) 2006-11-23
EP1831248B1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
ZA200705087B (en) Pasteurella multocida vaccine
CY1119284T1 (el) ΣΩΜΑΤΙΔΙΑ ΠΑΡΟΜΟΙΑ ΜΕ ΙΟ ΓΛΥΚΟ-ΠΡΩΤΕΪΝΗΣ ΛΥΣΣΑΣ (VLPs)
CY1118090T1 (el) Αντιγονα ανασυνδυασμενου rsv
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
MX2021001659A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
CY1114690T1 (el) Αντισωματα αντι-nrr notch1 και μεθοδοι χρησεις αυτων
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
ATE426412T1 (de) Adjuvante influenza-vakzine
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
CR11731A (es) Composiciones y procedimientos para su preparación y uso
BRPI0520330B8 (pt) adjuvante a base de ácido polinosínico-policitidílico
MX2009008928A (es) Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas.
BRPI0508064A (pt) flavivìrus, composição de vacina e molécula de ácido nucléico
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
MY151051A (en) Vaccination against dengue virus infection
WO2009059170A9 (en) Ehrlichia canis diva (differentiate infection from vaccinated animals)
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
WO2012079878A3 (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2008043000A3 (en) Ehrlicia canis diva (differentiate infected from vaccinated animals)
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
CL2008000856A1 (es) Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.
ATE518012T1 (de) Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
EA201290319A1 (ru) Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания
ATE535253T1 (de) Impfstoff gegen mycoplasma prrsv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties